Compare EVTC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVTC | INSP |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United States | United States |
| Employees | N/A | 1333 |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2013 | 2018 |
| Metric | EVTC | INSP |
|---|---|---|
| Price | $27.82 | $75.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 16 |
| Target Price | $35.80 | ★ $94.00 |
| AVG Volume (30 Days) | 339.7K | ★ 614.0K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | 27.17 | ★ 179.43 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $453,869,000.00 | $82,050,000.00 |
| Revenue This Year | $12.68 | $8.02 |
| Revenue Next Year | $6.86 | $8.11 |
| P/E Ratio | $58.67 | ★ N/A |
| Revenue Growth | 11.48 | ★ 62.18 |
| 52 Week Low | $21.81 | $38.91 |
| 52 Week High | $34.77 | $147.03 |
| Indicator | EVTC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 72.08 |
| Support Level | $27.64 | $55.37 |
| Resistance Level | $30.40 | $86.00 |
| Average True Range (ATR) | 0.92 | 3.58 |
| MACD | -0.21 | 0.75 |
| Stochastic Oscillator | 12.57 | 82.07 |
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.